CoChat

AUTOIMMUNE RETINOPATHY AND ANTIRETINAL ANTIBODIES: A REVIEW

Grewal, Dilraj S., Fishman, Gerald A., Jampol, Lee M. · 2014 · Retina
Cited by 173

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

In Brief Purpose: To review the current state for diagnosis and management of autoimmune retinopathy. Methods: A review of the literature was performed, encompassing autoimmune retinopathy including paraneoplastic retinopathy (cancer-associated retinopathy, melanoma-associated retinopathy, and bilateral diffuse uveal melanocytic proliferation) and non-paraneoplastic autoimmune retinopathy. Based on this review, current principles and techniques for diagnosis and the treatments reported for autoimmune retinopathy are discussed with the aim to clarify some of the confusion that exists regarding this complex entity. Results: Autoimmune retinopathy encompasses a spectrum of retinal degeneration phenotypes. The clinical features, fundus characteristics, and electroretinogram findings for paraneoplastic and non-paraneoplastic retinopathy are reviewed. The different antiretinal antibodies reported in these entities are described. The diagnostic approaches for detecting these antiretinal antibodies and their limitations are covered. The treatments reported for autoimmune retinopathy and their outcomes are reviewed. Conclusion: Among the myriad of antiretinal antibodies reported, challenges persist in determining which antibodies are pathogenic and which are benign and what factors cause antiretinal antibodies to become pathologic. There also remain difficulties in the detection and accurate measurement of antiretinal antibodies, and the response to therapeutic intervention in autoimmune retinopathy is variable. This review covers autoimmune retinopathy describing paraneoplastic retinopathy (cancer-associated retinopathy, melanoma-associated retinopathy, and bilateral diffuse uveal melanocytic proliferation) and non-paraneoplastic autoimmune retinopathy. The diagnostic utility and methods for detecting antiretinal antibodies associated with autoimmune retinopathy are discussed. The various treatments published for autoimmune retinopathy and their reported outcomes are reviewed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/iae.0000000000000119

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 111

  1. Weleber, 2005, . Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies., Am J Ophthalmol, 139, 780, 10.1016/j.ajo.2004.12.104 · DOI · Paper page
  2. Jampol, 2004, . Multiple serous retinal detachments and subretinal deposits as the presenting signs of metastatic melanoma., Retina, 24, 320, 10.1097/00006982-200404000-00028 · DOI
  3. Pelosof, 2010, Paraneoplastic syndromes: an approach to diagnosis and treatment., Mayo Clin Proc, 85, 838, 10.4065/mcp.2010.0099 · DOI · Paper page
  4. Forooghian, 2008, . The need for standardization of antiretinal antibody detection and measurement., Am J Ophthalmol, 146, 489, 10.1016/j.ajo.2008.05.046 · DOI
  5. Whitcup, 1998, . Recoverin-associated retinopathy: a clinically and immunologically distinctive disease., Am J Ophthalmol, 126, 230, 10.1016/S0002-9394(98)00149-4 · DOI
  6. Adamus, 2004, Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy., BMC Ophthalmol, 4, 1, 10.1186/1471-2415-4-5 · DOI · Paper page
  7. Keltner, 1992, . Management and monitoring of cancer-associated retinopathy., Arch Ophthalmol, 110, 48, 10.1001/archopht.1992.01080130050025 · doi:10.1001/archopht.1992.01080130050025
  8. Sawyer, 1976, . Blindness caused by photoreceptor degeneration as a remote effect of cancer., Am J Ophthalmol, 81, 606, 10.1016/0002-9394(76)90125-2 · doi:10.1016/0002-9394(76)90125-2
  9. Polans, 1993, . Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy., Invest Ophthalmol Vis Sci, 34, 81
  10. Polans, 1995, . Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy., Proc Natl Acad Sci U S A, 92, 9176, 10.1073/pnas.92.20.9176 · DOI · Paper page
  11. Guy, 1999, Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases., Arch Ophthalmol, 117, 471, 10.1001/archopht.117.4.471 · doi:10.1001/archopht.117.4.471
  12. Goldstein, 1999, . Cancer-associated retinopathy., Arch Ophthalmol, 117, 1641, 10.1001/archopht.117.12.1641 · doi:10.1001/archopht.117.12.1641
  13. Adamus, 1998, . Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy., Arch Ophthalmol, 116, 251
  14. Eltabbakh, 1995, Paraneoplastic retinopathy associated with uterine sarcoma., Gynecol Oncol, 58, 120, 10.1006/gyno.1995.1194 · doi:10.1006/gyno.1995.1194
  15. Heckenlively, 2000, . Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration., Arch Ophthalmol, 118, 1525, 10.1001/archopht.118.11.1525 · DOI · Paper page
  16. Heckenlively, 2008, Autoimmune retinopathy: a review and summary., Semin Immunopathol, 30, 127, 10.1007/s00281-008-0114-7 · DOI · Paper page
  17. Adamus, 2009, Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy., Autoimmun Rev, 8, 410, 10.1016/j.autrev.2009.01.002 · DOI · Paper page
  18. Khan, 2006, Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome., Semin Ophthalmol, 21, 135, 10.1080/08820530500350662 · DOI
  19. Scholl, 2000, Electrophysiology in the investigation of acquired retinal disorders., Surv Ophthalmol, 45, 29, 10.1016/S0039-6257(00)00125-9 · DOI
  20. Spaide, 2011, Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model., Retina, 31, 1609, 10.1097/IAE.0b013e3182247535 · DOI · Paper page
  21. Pepple, 2013, . SD-OCT and autofluorescence characteristics of autoimmune retinopathy., Br J Ophthalmol, 97, 139, 10.1136/bjophthalmol-2012-302524 · doi:10.1136/bjophthalmol-2012-302524
  22. Lima, 2012, . Hyperautofluorescent ring in autoimmune retinopathy., Retina, 32, 1385, 10.1097/IAE.0b013e3182398107 · DOI
  23. Thirkill, 1992, . The cancer-associated retinopathy antigen is a recoverin-like protein., Invest Ophthalmol Vis Sci, 33, 2768
  24. Bazhin, 2007, . Recoverin as a cancer-retina antigen., Cancer Immunol Immunother, 56, 110, 10.1007/s00262-006-0132-z · DOI
  25. Adamus, 2006, . Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells., J Autoimmun, 26, 146, 10.1016/j.jaut.2005.11.007 · DOI
  26. Thirkill, 1997, Experimental, cancer-induced retinopathy., Ocul Immunol Inflamm, 5, 55, 10.3109/09273949709085051 · DOI
  27. Shiraga, 2002, Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway., J Neuroimmunol, 132, 72, 10.1016/S0165-5728(02)00314-4 · DOI
  28. Mizener, 1997, . Autoimmune retinopathy in the absence of cancer., Am J Ophthalmol, 123, 607, 10.1016/S0002-9394(14)71073-6 · DOI
  29. Adamus, 1996, . The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy., Clin Immunol Immunopathol, 78, 120, 10.1006/clin.1996.0021 · DOI · Paper page
  30. Mosca, 2006, . Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus., J Rheumatol, 33, 695
  31. Heckenlively, 1999, Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa., Am J Ophthalmol, 127, 565, 10.1016/S0002-9394(98)00446-2 · DOI
  32. Grossman, 2011, . Immunocytochemical evidence of Tulp1-dependent outer segment protein transport pathways in photoreceptor cells., Exp Eye Res, 93, 658, 10.1016/j.exer.2011.08.005 · DOI
  33. Kikuchi, 2000, . Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy., J Neuroimmunol, 103, 26, 10.1016/S0165-5728(99)00163-0 · DOI
  34. Ohguro, 1999, Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy., Invest Ophthalmol Vis Sci, 40, 82
  35. Hsu, 1990, Glyceraldehyde-3-phosphate dehydrogenase is a major protein associated with the plasma membrane of retinal photoreceptor outer segments., J Biol Chem, 265, 13308, 10.1016/S0021-9258(19)38299-7 · DOI · Paper page
  36. Adamus, 2011, . Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy., J Ophthalmic Inflamm Infect, 1, 111, 10.1007/s12348-011-0028-8 · DOI
  37. Ferreyra, 2009, . Management of autoimmune retinopathies with immunosuppression., Arch Ophthalmol, 127, 390, 10.1001/archophthalmol.2009.24 · DOI · Paper page
  38. Murphy, 1997, Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma., J Neuroophthalmol, 17, 77, 10.1097/00041327-199706000-00001 · DOI
  39. Huynh, 2012, . Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy., J Ophthalmic Inflamm Infect, 2, 169, 10.1007/s12348-012-0067-9 · doi:10.1007/s12348-012-0067-9
  40. Or, 2013, . Intravenous rituximab for the treatment of cancer-associated retinopathy., Can J Ophthalmol, 48, e35, 10.1016/j.jcjo.2012.11.010 · DOI
  41. Mahdi, 2010, . A case of autoimmune retinopathy associated with thyroid carcinoma., Ocul Immunol Inflamm, 18, 322, 10.3109/09273941003802379 · DOI
  42. Espandar, 2007, . Successful treatment of cancer-associated retinopathy with alemtuzumab., J Neurooncol, 83, 295, 10.1007/s11060-006-9326-7 · doi:10.1007/s11060-006-9326-7
  43. Prins, 2007, Intravenous immunoglobulin: properties, mode of action and practical use in dermatology., Acta Derm Venereol, 87, 206, 10.2340/00015555-0249 · DOI
  44. Kiratli, 1997, . Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site., Eye (Lond), 11, 889, 10.1038/eye.1997.227 · doi:10.1038/eye.1997.227
  45. Keltner, 2001, Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases., J Neuroophthalmol, 21, 173, 10.1097/00041327-200109000-00004 · DOI · Paper page
  46. Okel, 1995, An unusual case of melanoma-associated retinopathy., Ocul Immunol Inflamm, 3, 121, 10.3109/09273949509085040 · doi:10.3109/09273949509085040
  47. Nieuwendijk, 2007, Paraneoplastic vitelliform retinopathy associated with metastatic choroidal melanoma., Eye (Lond), 21, 1436, 10.1038/sj.eye.6702949 · DOI
  48. Grunwald, 2011, Acute exudative polymorphous paraneoplastic vitelliform maculopathy in a patient with carcinoma, not melanoma., Arch Ophthalmol, 129, 1104, 10.1001/archophthalmol.2011.215 · doi:10.1001/archophthalmol.2011.215
  49. Koreen, 2011, . Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis., Arch Ophthalmol, 129, 23, 10.1001/archophthalmol.2010.316 · DOI
  50. Borkowski, 2001, . Retinal findings in melanoma-associated retinopathy., Am J Ophthalmol, 132, 273, 10.1016/S0002-9394(01)00915-1 · doi:10.1016/s0002-9394(01)00915-1
  51. Zacks, 2001, . Melanoma-associated retinopathy and recurrent exudative retinal detachments in a patient with choroidal melanoma., Am J Ophthalmol, 132, 578, 10.1016/S0002-9394(01)01086-8 · DOI
  52. Milam, 1993, . Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy., Invest Ophthalmol Vis Sci, 34, 91
  53. Potter, 2002, . Autoantibodies to transducin in a patient with melanoma-associated retinopathy., Am J Ophthalmol, 134, 128, 10.1016/S0002-9394(02)01431-9 · DOI
  54. Hartmann, 2005, . SEREX identification of new tumor antigens linked to melanoma-associated retinopathy., Int J Cancer, 114, 88, 10.1002/ijc.20762 · DOI
  55. Bazhin, 2009, The need for standardization of antiretinal antibody detection and measurement., Am J Ophthalmol, 147, 374, 10.1016/j.ajo.2008.10.014 · doi:10.1016/j.ajo.2008.10.014
  56. Eksandh, 2008, . Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma., Arch Ophthalmol, 126, 432, 10.1001/archopht.126.3.432 · DOI
  57. Marmorstein, 2000, . Bestrophin, the product of the best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium., Proc Natl Acad Sci U S A, 97, 12758, 10.1073/pnas.220402097 · DOI · Paper page
  58. Morgans, 2009, . TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells., Proc Natl Acad Sci U S A, 106, 19174, 10.1073/pnas.0908711106 · DOI · Paper page
  59. Kondo, 2011, . Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction., PLoS One, 6, e19911, 10.1371/journal.pone.0019911 · DOI
  60. Dhingra, 2011, . Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells., J Neurosci, 31, 3962, 10.1523/JNEUROSCI.6007-10.2011 · doi:10.1523/jneurosci.6007-10.2011
  61. Nakamura, 2010, . TRPM1 mutations are associated with the complete form of congenital stationary night blindness., Mol Vis, 16, 425
  62. Wang, 2012, . Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy., BMC Ophthalmol, 12, 56, 10.1186/1471-2415-12-56 · DOI
  63. Arai, 1994, . Position-independent, high-level, and correct regional expression of the rat aldolase C gene in the central nervous system of transgenic mice., Eur J Biochem, 221, 253, 10.1111/j.1432-1033.1994.tb18736.x · DOI
  64. Caffe, 1994, . Distribution of Purkinje cell-specific Zebrin-IIaldolase C immunoreactivity in the mouse, rat, rabbit, and human retina., J Comp Neurol, 348, 291, 10.1002/cne.903480210 · doi:10.1002/cne.903480210
  65. Tanito, 2006, . Identification of 4-hydroxynonenal-modified retinal proteins induced by photooxidative stress prior to retinal degeneration., Free Radic Biol Med, 41, 1847, 10.1016/j.freeradbiomed.2006.09.012 · DOI
  66. Lu, 2009, . Melanoma-associated retinopathy: a paraneoplastic autoimmune complication., Arch Ophthalmol, 127, 1572, 10.1001/archophthalmol.2009.311 · DOI
  67. Ahn, 2006, . Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis., Proteomics, 6, 1200, 10.1002/pmic.200500457 · DOI
  68. Morohoshi, 2009, . Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration., J Autoimmun, 33, 247, 10.1016/j.jaut.2009.09.003 · DOI
  69. Ukaji, 1999, . Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to denatured aldolase A in the osteoblast-like cell line, MG-63., Ann Rheum Dis, 58, 169, 10.1136/ard.58.3.169 · DOI
  70. Mor, 2005, Identification of aldolase as a target antigen in Alzheimers disease., J Immunol, 175, 3439, 10.4049/jimmunol.175.5.3439 · DOI · Paper page
  71. Korf, 1992, . Immunocytochemical demonstration of interphotoreceptor retinoid-binding protein in cerebellar medulloblastoma., Acta Neuropathol, 83, 482, 10.1007/BF00310024 · DOI
  72. Powell, 2010, Treatment of melanoma-associated retinopathy., Curr Treat Options Neurol, 12, 54, 10.1007/s11940-009-0057-x · doi:10.1007/s11940-009-0057-x
  73. Subhadra, 2008, . Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin., J Neuroophthalmol, 28, 23, 10.1097/WNO.0b013e31816754c4 · doi:10.1097/wno.0b013e31816754c4
  74. Dalakas, 1998, Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases., Neurology, 51, S2, 10.1212/WNL.51.6_Suppl_5.S2 · DOI
  75. Jacobzone, 2004, . Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings., Arch Dermatol, 140, 1258, 10.1001/archderm.140.10.1258 · doi:10.1001/archderm.140.10.1258
  76. Gass, 1990, . Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma., Arch Ophthalmol, 108, 527, 10.1001/archopht.1990.01070060075053 · doi:10.1001/archopht.1990.01070060075053
  77. ONeal, 2003, . Bilateral diffuse uveal melanocytic proliferation associated with pancreatic carcinoma: a case report and literature review of this paraneoplastic syndrome., Surv Ophthalmol, 48, 613, 10.1016/j.survophthal.2003.08.005 · doi:10.1016/j.survophthal.2003.08.005
  78. Mandelcorn, 2009, . Ocular paraneoplastic syndrome: a case of bilateral diffuse uveal melanocytic proliferation., Retina, 29, 1375, 10.1097/IAE.0b013e3181b2106b · doi:10.1097/iae.0b013e3181b2106b
  79. Chahud, 2001, . Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers: review of a process particularly associated with gynecologic cancers., Am J Surg Pathol, 25, 212, 10.1097/00000478-200102000-00009 · doi:10.1097/00000478-200102000-00009
  80. Miles, 2012, . A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes., Retina, 32, 1959, 10.1097/IAE.0b013e3182618bab · doi:10.1097/iae.0b013e3182618bab
  81. Rohrbach, 1990, . Simultaneous bilateral diffuse melanocytic uveal hyperplasia., Am J Ophthalmol, 110, 49, 10.1016/S0002-9394(14)76937-5 · doi:10.1016/s0002-9394(14)76937-5
  82. Sen, 2006, . Presymptomatic diagnosis of bronchogenic carcinoma associated with bilateral diffuse uveal melanocytic proliferation., Clin Experiment Ophthalmol, 34, 156, 10.1111/j.1442-9071.2006.01145.x · doi:10.1111/j.1442-9071.2006.01145.x
  83. Saito, 2005, . Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy., Am J Ophthalmol, 140, 942, 10.1016/j.ajo.2005.05.048 · doi:10.1016/j.ajo.2005.05.048
  84. Mets, 2011, . Bilateral diffuse uveal melanocytic proliferation with a positive ophthalmoscopic and visual response to plasmapheresis., Arch Ophthalmol, 129, 1235, 10.1001/archophthalmol.2011.277 · doi:10.1001/archophthalmol.2011.277
  85. Jaben, 2011, . The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases., J Clin Apher, 26, 356, 10.1002/jca.20310 · doi:10.1002/jca.20310
  86. Ritland, 2000, Bilateral diffuse uveal melanocytic proliferation and uterine cancer. A case report., Acta Ophthalmol Scand, 78, 366, 10.1034/j.1600-0420.2000.078003366.x · doi:10.1034/j.1600-0420.2000.078003366.x
  87. Heckenlively, 1985, . Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings., Br J Ophthalmol, 69, 758, 10.1136/bjo.69.10.758 · DOI
  88. Adamus, 2009, Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies., Exp Mol Pathol, 87, 195, 10.1016/j.yexmp.2009.08.003 · DOI
  89. Dawson, 2001, . Distant cancer effects on standardised testing of peripheral vision., Br J Ophthalmol, 85, 291, 10.1136/bjo.85.3.291 · doi:10.1136/bjo.85.3.291
  90. Ohta, 2011, Slowly progressive non-neoplastic autoimmune-like retinopathy., Graefes Arch Clin Exp Ophthalmol, 249, 155, 10.1007/s00417-010-1436-4 · doi:10.1007/s00417-010-1436-4
  91. Peek, 1998, . Muller cell-specific autoantibodies in a patient with progressive loss of vision., Invest Ophthalmol Vis Sci, 39, 1976
  92. Adamus, 2009, Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy., J Autoimmun, 32, 133, 10.1016/j.jaut.2009.02.001 · DOI
  93. Heckenlively, 2010, Controversies of diagnosing autoimmune retinopathy., Arch Ophthalmol, 128, 147
  94. Heckenlively, 2010, Controversies of diagnosing autoimmune retinopathy., Arch Ophthalmol, 128, 147
  95. Braithwaite, 2012, Autoimmune retinopathy., Ophthalmologica, 228, 131, 10.1159/000338240 · DOI
  96. Faez, 2013, Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy., JAMA Ophthalmol, 131, 113, 10.1001/jamaophthalmol.2013.574 · doi:10.1001/jamaophthalmol.2013.574
  97. Rahimy, 2013, Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management., Surv Ophthalmol, 58, 430, 10.1016/j.survophthal.2012.09.001 · DOI · Paper page
  98. Grange, 2014, Autoimmune retinopathy., Am J Ophthalmol, 157, 266, 10.1016/j.ajo.2013.09.019 · DOI
  99. Wood, 2010, . Alloimmune retinopathy associated with antibodies to transducin-alpha as a complication of chronic graft-versus-host disease., Biol Blood Marrow Transplant, 16, 135, 10.1016/j.bbmt.2009.06.012 · DOI
  100. Shimazaki, 2008, . Frequency of anti-retinal antibodies in normal human serum., J Neuroophthalmol, 28, 5, 10.1097/WNO.0b013e318167549f · DOI
  101. Wolfensberger, 2000, . Antiretinal antibodies associated with cystoid macular edema in German., Klin Monbl Augenheilkd, 216, 283, 10.1055/s-2000-10561 · DOI
  102. Chan, 1985, . Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcets disease, and sympathetic ophthalmia., Ophthalmology, 92, 1025, 10.1016/S0161-6420(85)33911-8 · DOI
  103. Chan, 1987, . Immunopathology of ocular onchocerciasis. 2. Anti-retinal autoantibodies in serum and ocular fluids., Ophthalmology, 94, 439, 10.1016/S0161-6420(87)33452-9 · doi:10.1016/s0161-6420(87)33452-9
  104. Whittle, 1998, . Human antiretinal antibodies in toxoplasma retinochoroiditis., Br J Ophthalmol, 82, 1017, 10.1136/bjo.82.9.1017 · doi:10.1136/bjo.82.9.1017
  105. Yanagi, 2006, . Autoimmune retinopathy after chronic renal allograft rejection., Arch Ophthalmol, 124, 418, 10.1001/archopht.124.3.418 · doi:10.1001/archopht.124.3.418
  106. Dot, 2005, Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung., Am J Ophthalmol, 139, 746, 10.1016/j.ajo.2004.10.044 · DOI
  107. Saito, 2013, . Autoimmune retinopathy associated with colonic adenoma., Graefes Arch Clin Exp Ophthalmol, 251, 1447, 10.1007/s00417-012-2131-4 · doi:10.1007/s00417-012-2131-4
  108. Pfohler, 2007, . Mitofilin and titin as target antigens in melanoma-associated retinopathy., Int J Cancer, 120, 788, 10.1002/ijc.22384 · DOI
  109. Mahdi, 2010, A case of autoimmune retinopathy associated with thyroid carcinoma., Ocul Immunol Inflamm, 18, 322, 10.3109/09273941003802379 · DOI
  110. Palmowski, 2002, . Bilateral multifocal chorioretinopathy in a woman with cutaneous malignant melanoma., Arch Ophthalmol Dec, 120, 1756
  111. Adamus, 2009, Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy., Autoimmun Rev Mar, 8, 410, 10.1016/j.autrev.2009.01.002 · DOI · Paper page

Cited by

See all 173

Metadata

Authors
Grewal, D. S., Fishman, G. A., & Jampol, L. M.
Venue
Retina
Published
2014-05
Volume
34
Issue
5
Pages
827-845
ISSN
0275-004X (ISSN-L)
OpenAlex
W1983535430
Cited by
173
References
4
FWCI
7.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AUTOIMMUNE RETINOPATHY AND ANTIRETINAL ANTIBODIES: A REVIEW. https://app.cochat.ai/papers/10.1097/iae.0000000000000119
The paper
Grewal, D. S., Fishman, G. A., & Jampol, L. M. (2014). AUTOIMMUNE RETINOPATHY AND ANTIRETINAL ANTIBODIES: A REVIEW. Retina. https://doi.org/10.1097/iae.0000000000000119

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.